(Q33974041)

30 July 2017

title

Rofecoxib reduces polyp recurrence in familial polyposis (English)

1 reference

30 July 2017

1 reference

Hallak A

1

1 reference

30 July 2017

Alon-Baron L

2

1 reference

30 July 2017

Shamir R

3

1 reference

30 July 2017

Moshkowitz M

4

1 reference

30 July 2017

Bulvik B

5

1 reference

30 July 2017

Brazowski E

6

1 reference

30 July 2017

Halpern Z

7

1 reference

30 July 2017

Arber N

8

1 reference

30 July 2017

publication date

1 October 2003

1 reference

Digestive Diseases and Sciences

30 July 2017

published in

1 reference

30 July 2017

volume

48

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

1998-2002

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1026130623186

30 July 2017

exact match

0 references

cites work

Human cyclooxygenase-2 cDNA

1 reference

12 December 2020

Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome

1 reference

12 December 2020

Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing ad

1 reference

12 December 2020

Aspirin use and potential mechanisms for colorectal cancer prevention

1 reference

12 December 2020

Sulindac for polyposis of the colon.

1 reference

12 December 2020

Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis

1 reference

12 December 2020

Cancer research. Anti-inflammatories inhibit cancer growth--but how?

1 reference

12 December 2020

Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study

1 reference

12 December 2020

Colon cancer prevention by NSAIDs: what is the mechanism of action?

1 reference

12 December 2020

Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis.

1 reference

12 December 2020

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

1 reference

12 December 2020

Colonic adenomas: prevalence and incidence rates, growth rates, and miss rates at colonoscopy

1 reference

12 December 2020

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

12 December 2020

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

12 December 2020

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

1 reference

12 December 2020

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

12 December 2020

Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy

1 reference

12 December 2020

Primary chemoprevention of familial adenomatous polyposis with sulindac

1 reference

12 December 2020

Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer?

1 reference

12 December 2020

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

12 December 2020

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

12 December 2020

The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis

1 reference

12 December 2020

Do NSAIDs prevent colorectal cancer?

1 reference

12 December 2020

Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus

1 reference

12 December 2020

Identification of FAP locus genes from chromosome 5q21

1 reference

12 December 2020

Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor

1 reference

12 December 2020

Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1026130623186

1 reference

Dimensions Publication ID

30 July 2017

1002159697

0 references

1 reference